DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/d8d2k4/research_report) has announced the addition of the "Concise Analysis of the International and Chinese In-Vitro Diagnostic Reagent Industry" report to their offering.
In Chinese market, there are mainly three categories of in-vitro diagnostic reagents, biochemical diagnostic reagents, immune diagnostic reagents and molecular diagnostic reagents, accounting for about 65% of in-vitro diagnostic reagent market in total in 2012. Global in-vitro diagnostics market is mature and the concentration rate is high. The 8 major enterprises account for over 70% market share.
In 2011, the market scale of global in-vitro diagnostics reached USD 46 billion, among which developed countries accounted for over 80%. Currently, emerging economic entities occupy low proportions, while their growth rates are far ahead of that of mature markets.
In China, barriers to entry of this industry are not high and the concentration rate is low. The majority of enterprises concentrate in the biochemical reagent field, so the competition is mainly in the biochemical field. Both the supply and demand of immune and molecular products are prosperous. In addition to immune reagents, markets of other diagnostic reagents are mainly occupied by Chinese domestic enterprises.
Key Topics Covered:
1 Overview on In-vitro Diagnostic Reagent Industry
2 Global In-vitro Diagnostic Reagent Industry, 2011-2013
3 Development Environment of China In-vitro Diagnostic Reagent Industry, 2011-2013
4 Operation Status of China Diagnostic Reagent Industry, 2008-2012
5 Top 5 Enterprises of China's In-vitro Diagnostic Reagent Industry, 2011-2013
6 Prospect of China In-vitro Diagnostic Reagent Industry, 2013-2017
For more information visit http://www.researchandmarkets.com/research/d8d2k4/research_report
Source: Research and Markets